ABCB1 and Alzheimer disease: Finally, reducing the accumulation of Aβ in the brain would also lead to a decrease in the levels of pro-inflammatory cytokines from microglia, limiting the down-regulatory effects of these cytokines on ABCB1, and interrupting the positive feedback loop between Aβ and neuro-inflammation that may be critical to disease progression in AD.